Skip to content

This study will test whether the InnerGize smart patch is safe and works well in reducing stress and anxiety. It will compare the Sham Device patch in healthy volunteers to see if it helps people relax and manage stress better.

An Investigator-Initiated Prospective, Open Labelled Comparative Study to Evaluate the Clinical Outcomes Like Performance, Effectiveness, and Safety of a Non-Invasive Smart Patch InnerGize and Sham device to Reduce Stress and Anxiousness and promote relaxation in Healthy Volunteers. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091925
Enrollment
200
Registered
2025-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Non-Invasive Smart Patch InnerGize: InnerGize is a non-invasive, safe and clinically tested device. InnerGize has gone through rigorous testing ensuring safety and maximum effectiveness

Sponsors

Ezymind Healthcare Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male or Female patients in the age group from 18 to 60 years. 2. Healthy volunteers stressed out due to the daily routine, work related for at least 2 weeks without receiving any alternative treatment in the past 3 months will be deemed suitable as per eligibility and will be approached regarding enrolment in the study. 3. Patients who are willing to provide a written informed consent form before initiation of the study. 4. Participants who are willing and able to comply with all study assessments and adhere to the protocol schedule.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating mother. 2. Patients with metallic and active implants in their body, such as pacemakers or hearing aids, should refrain from using the product 3. Patients with uncontrolled hypertension, cardiovascular diseases, or a history of Seizures 4. Significant systemic illness or occult systemic illness, or any other care or medication which may interfere with the InnerGize care 5. Not willing to obtain a written informed consent form to participate in the study. 6. Patients involved in clinical trials and taken similar investigational products within 3 months before initiation of the study. 7. Any severe, acute, or chronic medical condition that may affect the patients ability to participate in the study, may lead to unacceptable security risks and non-compliance with protocol procedures or may interfere with the interpretation of the study results.

Design outcomes

Primary

MeasureTime frame
To evaluate the performance outcomes like variations in stress, anxiousness and relaxation, experienced by Healthy Volunteers with the Non-Invasive Smart Patch InnerGize arm and a sham device arm throughout the study period.Timepoint: Day 1 - (Visit-I) Screening + Treatment - Pre stimulation + Post stimulation Day 2 - (Visit II) - Telephonic Follow up Day 3 - (Visit III) - Telephonic Follow up Day 4 - (Visit IV) - Telephonic Follow up

Secondary

MeasureTime frame
Change in Customized questionnaire before the session (pre-stimulation) & after the session (post-stimulation) with Non-Invasive Smart Patch InnerGize & Sham device.Timepoint: Day 1 - (Visit-I) Screening & treatment Day 2 - (Visit II) - Telephonic Follow up Day 3 - (Visit III) - Telephonic Follow up Day 4 - (Visit IV) - Telephonic Follow up

Countries

India

Contacts

Public ContactDr Ashwini Kumar

CliniExperts Research Services Pvt. Ltd.

veena.rm@cliniexpertsresearch.com9880902005

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026